This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
fin-tech: Archive
3 Intriguing Dividend Stocks to Buy Now: AGRO, AU, DLX
by Shaun Pruitt
It's not always easy to find fairly valued, dividend-generating stocks with compelling or expanding niches in their industries.
AUNegative Net Change AGROPositive Net Change DLXNegative Net Change PYPLPositive Net Change XYZNegative Net Change
agriculture basic-materials business-services dividend-investing dividends earnings fin-tech gold investing payments precious-metals
Regency Centers (REG) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
REGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Scor SE (SCRYY)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
SCRYYNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
4 Top-Ranked Stocks With Solid Net Profit Margins to Enhance Returns
by Anirudha Bhagat
Enhance your portfolio with ENVA, SNEX, SHIP and FLXS, each exhibiting strong net profit margins and steady earnings growth.
FLXSNegative Net Change ENVANegative Net Change SHIPPositive Net Change SNEXNegative Net Change
consumer-discretionary fin-tech finance furniture-retailers transportation
What Was Behind Pagaya's Positive GAAP Earnings in 2025?
by Nikita Kataruka
PGY swings to record GAAP profit in 2025 as revenues jump 26% year over year and margins expand.
TREENegative Net Change UPSTNegative Net Change PGYPositive Net Change
fin-tech finance
PYPL's Transaction Revenues: Will it Pave the Way or Hinder Growth?
by Zacks Equity Research
PayPal's Q4 transaction revenues rise 3% to $7.82B, but a lower transaction take rate and a flat 2026 TM$ outlook cloud its growth trajectory.
PYPLPositive Net Change PAYONegative Net Change XYZNegative Net Change
fin-tech
Klarna Set to Report Q4 Earnings: Key Factors Investors Should Watch
by Zacks Equity Research
KLAR readies Q4 results with 18.5% revenue growth expected and GMV near $38B as consumer receivables are likely to have increased.
AXPNegative Net Change AFRMPositive Net Change KLARNegative Net Change
business-services earnings fin-tech finance payments
Euronet Q4 Earnings Miss Estimates on Increasing Expenses
by Zacks Equity Research
EEFT's Q4 EPS misses estimates as expenses climb and U.S. reforms hit transfers, even as revenues rise and full-year profit grows.
MANegative Net Change VNegative Net Change EEFTNegative Net Change MRSHPositive Net Change
business-services earnings fin-tech payments
ServisFirst Bancshares (SFBS)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
SFBSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Healthy Global Loan Issuance Volumes to Drive Moody's Q4 Earnings
by Zacks Equity Research
MCO heads into Feb. 18 earnings with healthy Q4 loan and bond issuance driving MIS growth, while Analytics demand and rising acquisition costs shape results.
ACNNegative Net Change MCONegative Net Change SPGINegative Net Change
earnings fin-tech finance